Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic

148
24
Favorite

Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic

Tiger Newspress2022-03-17

Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.

Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.

Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.

According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.

Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.

However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

148

Report

Comment（24）

Camemberu
·2022-03-18
Relax, he made the sale of shares accordingto the 2018 10b5-1 plans. That's how they get paid.
Reply
1
Report
BenjiFuji
·2022-03-18
Why he need so much cash suddenly? Red flag?
Reply
1
Report
1b4a34ed
·2022-03-18
Not a good sign...
Reply
1
Report
andrew123
·2022-03-18
Like
Reply
1
Report
IN76
·2022-03-18
That is not a good sign when its CEO offload thecompany's shares in such a large amount. As retail investors, we have to be careful.
Reply
3
Report
ACCY
·2022-03-17
Hmm something fishy! 🤨
Reply
2
Report
kaeni
·2022-03-17
Fishy fishy
Reply
2
Report
SiewWeng
·2022-03-17
nice
Reply
2
Report
ynwaben
·2022-03-17
Haha
Reply
4
Report
Sim1
·2022-03-17
$$$
Reply
2
Report
Jayden86_
·2022-03-17
Ya
Reply
3
Report
Jl123456
·2022-03-17
ok
Reply
3
Report
CIG
·2022-03-17
I bought 2 shares, sold 1 at loss, keeping last 1 for time being.
Reply
3
Report
dnhos0005
·2022-03-17
Ok
Reply
2
Report
Tony0623
·2022-03-17
buy
Reply
5
Report
Runningdown
·2022-03-17
like pls
Reply
6
Report
KopiLim
·2022-03-17
Ok
Reply
5
Report
aaffsmcjje
·2022-03-17
Hahahaha. Kacing to d bank he said
Reply
7
Report
LWKJKK
·2022-03-17
Wonder why post now.. moreover, this news already posted early this year..
Reply
8
Report
Desmondsim
·2022-03-17
Like
Reply
3
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1173599014?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-03-17 22:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1173599014","market":"us","top_or_hot":-1,"title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","media":"Tiger Newspress","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n2022-03-17 22:07 北京时间&nbsp;&nbsp;&nbsp;<strong>Tiger Newspress</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has ...</p>\n\n<a href=\"\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MRNA","symbol_name":"Moderna, Inc.","start_time":0,"source_url":"","article_id":"1173599014","we_media_id":"1079075236","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","pubTimestamp":1647526060,"sourceInfo":null,"weMediaInfo":{"media_name":"Tiger Newspress","introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MRNA":"Moderna, Inc."},"translate_title":"莫德纳的股价在早盘交易中下跌3%，因为其首席执行官在疫情期间出售了超过4亿美元的公司股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MRNA":0.9},"content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9035147080,"gmtCreate":1647558798375,"gmtModify":1676534243097,"author":{"id":"3574372734093079","authorId":"3574372734093079","name":"Camemberu","avatar":"https://static.tigerbbs.com/f6e006c4d0e8a340de0bf29e8c18ca51","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3574372734093079","authorIdStr":"3574372734093079"},"htmlText":"Relax, he made the sale of shares accordingto the 2018 10b5-1&nbsp;plans. That's how they get paid.&nbsp;","listText":"Relax, he made the sale of shares accordingto the 2018 10b5-1&nbsp;plans. That's how they get paid.&nbsp;","text":"Relax, he made the sale of shares accordingto the 2018 10b5-1 plans. That's how they get paid.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035147080","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035142859,"gmtCreate":1647558502441,"gmtModify":1676534243026,"author":{"id":"4110175785559852","authorId":"4110175785559852","name":"BenjiFuji","avatar":"https://community-static.tradeup.com/news/330f59d829009a2c318784ab2b5e6098","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":5,"crmLevelSwitch":0,"idStr":"4110175785559852","authorIdStr":"4110175785559852"},"htmlText":"Why he need so much cash suddenly? Red flag?","listText":"Why he need so much cash suddenly? Red flag?","text":"Why he need so much cash suddenly? Red flag?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035142859","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035154361,"gmtCreate":1647557715853,"gmtModify":1676534242844,"author":{"id":"4110517968648952","authorId":"4110517968648952","name":"1b4a34ed","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4110517968648952","authorIdStr":"4110517968648952"},"htmlText":"Not a good sign...","listText":"Not a good sign...","text":"Not a good sign...","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035154361","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035123734,"gmtCreate":1647554429765,"gmtModify":1676534242398,"author":{"id":"3576260758860416","authorId":"3576260758860416","name":"andrew123","avatar":"https://community-static.tradeup.com/news/f2a1eaba26272212d42018e60e78b422","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":5,"crmLevelSwitch":0,"idStr":"3576260758860416","authorIdStr":"3576260758860416"},"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035123734","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035164640,"gmtCreate":1647553023642,"gmtModify":1676534242303,"author":{"id":"3586219015705971","authorId":"3586219015705971","name":"IN76","avatar":"https://static.tigerbbs.com/984bfc5141365bf8942213556d53a7cf","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":6,"crmLevelSwitch":1,"idStr":"3586219015705971","authorIdStr":"3586219015705971"},"htmlText":"That is not a good sign when its CEO offload thecompany's shares in such a large amount. As retail investors, we have to be careful.&nbsp;","listText":"That is not a good sign when its CEO offload thecompany's shares in such a large amount. As retail investors, we have to be careful.&nbsp;","text":"That is not a good sign when its CEO offload thecompany's shares in such a large amount. As retail investors, we have to be careful.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035164640","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035133783,"gmtCreate":1647530676561,"gmtModify":1676534241291,"author":{"id":"3579758808989513","authorId":"3579758808989513","name":"ACCY","avatar":"https://static.tigerbbs.com/a44626552831eb06aa01cf85dcaf7422","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"3579758808989513","authorIdStr":"3579758808989513"},"htmlText":"Hmm something fishy! 🤨","listText":"Hmm something fishy! 🤨","text":"Hmm something fishy! 🤨","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035133783","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035197190,"gmtCreate":1647530025423,"gmtModify":1676534241206,"author":{"id":"4091415616262270","authorId":"4091415616262270","name":"kaeni","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4091415616262270","authorIdStr":"4091415616262270"},"htmlText":"Fishy fishy","listText":"Fishy fishy","text":"Fishy fishy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035197190","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035104613,"gmtCreate":1647528496338,"gmtModify":1676534240946,"author":{"id":"3585252654864862","authorId":"3585252654864862","name":"SiewWeng","avatar":"https://static.tigerbbs.com/53df5a10f848dd9d79558c4f7a3fb9f8","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3585252654864862","authorIdStr":"3585252654864862"},"htmlText":"nice","listText":"nice","text":"nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035104613","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035102629,"gmtCreate":1647528142495,"gmtModify":1676534240910,"author":{"id":"3581725251810238","authorId":"3581725251810238","name":"ynwaben","avatar":"https://static.tigerbbs.com/617ad5bc55468a1b0d22683027adc1e0","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581725251810238","authorIdStr":"3581725251810238"},"htmlText":"Haha","listText":"Haha","text":"Haha","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035102629","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035106686,"gmtCreate":1647527999943,"gmtModify":1676534240885,"author":{"id":"3573709257975993","authorId":"3573709257975993","name":"Sim1","avatar":"https://static.tigerbbs.com/45f90a5e23b6dc713a314a1c2365d6b6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573709257975993","authorIdStr":"3573709257975993"},"htmlText":"$$$","listText":"$$$","text":"$$$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035106686","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035108568,"gmtCreate":1647527897612,"gmtModify":1676534240859,"author":{"id":"3581853261599921","authorId":"3581853261599921","name":"Jayden86_","avatar":"https://static.tigerbbs.com/e0a3979b2998dfa9c0fddbce29da3ab9","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3581853261599921","authorIdStr":"3581853261599921"},"htmlText":"Ya&nbsp;","listText":"Ya&nbsp;","text":"Ya","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035108568","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035108217,"gmtCreate":1647527832080,"gmtModify":1676534240865,"author":{"id":"3581507104335566","authorId":"3581507104335566","name":"Jl123456","avatar":"https://static.tigerbbs.com/e33617eb88bce300e61abe733e239b98","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581507104335566","authorIdStr":"3581507104335566"},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035108217","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035108151,"gmtCreate":1647527782104,"gmtModify":1676534240856,"author":{"id":"3583974841960176","authorId":"3583974841960176","name":"CIG","avatar":"https://static.tigerbbs.com/6c2077e2370e1ffcaca7e29b875be2be","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":5,"crmLevelSwitch":1,"idStr":"3583974841960176","authorIdStr":"3583974841960176"},"htmlText":"I bought 2 shares, sold 1 at loss, keeping last 1 for time being.","listText":"I bought 2 shares, sold 1 at loss, keeping last 1 for time being.","text":"I bought 2 shares, sold 1 at loss, keeping last 1 for time being.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035108151","repostId":1173599014,"repostType":2,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035108072,"gmtCreate":1647527690389,"gmtModify":1676534240851,"author":{"id":"3571777241907892","authorId":"3571777241907892","name":"dnhos0005","avatar":"https://static.tigerbbs.com/1620be42110eb49d6fefba05ef25ab29","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3571777241907892","authorIdStr":"3571777241907892"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035108072","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035100002,"gmtCreate":1647526980361,"gmtModify":1676534240742,"author":{"id":"3579165302374821","authorId":"3579165302374821","name":"Tony0623","avatar":"https://static.tigerbbs.com/84dac78108a5811a8c221da360733dfd","vip":1,"crmLevel":8,"crmLevelSwitch":1,"idStr":"3579165302374821","authorIdStr":"3579165302374821"},"htmlText":"buy","listText":"buy","text":"buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035100002","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035377773,"gmtCreate":1647526957765,"gmtModify":1676534240761,"author":{"id":"3576550818064904","authorId":"3576550818064904","name":"Runningdown","avatar":"https://static.tigerbbs.com/ef91444757abfa72f3ede25e971f5398","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3576550818064904","authorIdStr":"3576550818064904"},"htmlText":"like pls","listText":"like pls","text":"like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035377773","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035377387,"gmtCreate":1647526832189,"gmtModify":1676534240715,"author":{"id":"3562886608344748","authorId":"3562886608344748","name":"KopiLim","avatar":"https://static.tigerbbs.com/04fcef53a2e715c173a40fafa14a7fe6","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":1,"idStr":"3562886608344748","authorIdStr":"3562886608344748"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035377387","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035374436,"gmtCreate":1647526733842,"gmtModify":1676534240754,"author":{"id":"3557887424829909","authorId":"3557887424829909","name":"aaffsmcjje","avatar":"https://static.tigerbbs.com/0fcb01cf792998a6ce47337ae22c20b9","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3557887424829909","authorIdStr":"3557887424829909"},"htmlText":"Hahahaha. Kacing to d bank he said","listText":"Hahahaha. Kacing to d bank he said","text":"Hahahaha. Kacing to d bank he said","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035374436","repostId":1173599014,"repostType":2,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035374238,"gmtCreate":1647526714980,"gmtModify":1676534240696,"author":{"id":"4096337009824130","authorId":"4096337009824130","name":"LWKJKK","avatar":"https://static.tigerbbs.com/c8865fe58cb1e2421bb5f60a39a8af3e","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"4096337009824130","authorIdStr":"4096337009824130"},"htmlText":"Wonder why post now.. moreover, this news already posted early this year..&nbsp;","listText":"Wonder why post now.. moreover, this news already posted early this year..&nbsp;","text":"Wonder why post now.. moreover, this news already posted early this year..","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035374238","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9035374692,"gmtCreate":1647526683266,"gmtModify":1676534240695,"author":{"id":"3581894830339885","authorId":"3581894830339885","name":"Desmondsim","avatar":"https://static.tigerbbs.com/9484cf4599b477a3985c44fe04da87b3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581894830339885","authorIdStr":"3581894830339885"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9035374692","repostId":1173599014,"repostType":4,"repost":{"id":"1173599014","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1647526060,"share":"https://ttm.financial/m/news/1173599014?lang=&edition=fundamental","pubTime":"2022-03-17 22:07","market":"us","language":"en","title":"Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic","url":"https://stock-news.laohu8.com/highlight/detail?id=1173599014","media":"Tiger Newspress","summary":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pa","content":"<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna Shares Fell 3% in Morning Trading as Its CEO Sold over $400m of Company Shares during the Pandemic\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-03-17 22:07</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.<img src=\"https://static.tigerbbs.com/5a155d56ea02435b6c830cd7e7de79f1\" tg-width=\"719\" tg-height=\"609\" referrerpolicy=\"no-referrer\"/></p><p>Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,<i>CNBC</i> reported Thursday, citing an analysis of the company’s securities filings.</p><p>Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.</p><p>According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.</p><li><p>Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.</p></li><li><p>However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.</p></li></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1173599014","content_text":"Moderna shares fell 3% in morning trading as its CEO sold over $400M of company shares during the pandemic.Stephane Bancel, Chief Executive of the COVID-19 vaccine maker Moderna (NASDAQ:MRNA), has offloaded $408 million worth of company shares since January 2020,CNBC reported Thursday, citing an analysis of the company’s securities filings.Equilar, a company providing data on executive compensation, has independently verified the value of Bancel’s sales. However, he has made the sales in line with the 10b5-1 stock plans adopted in 2018.According to the report, as Moderna (MRNA) shares surged with its successes in the COVID-19 vaccine front, Bancel has become a billionaire with an estimated net worth of more than $5.3 billion based only on his company equity as of March 01.Developed in partnership with the National Institutes of Health (NIH), Moderna’s (MRNA) vaccine is the second most widely used COVID-19 shot in the U.S.However, the company is battling several parties, including the NIH, for certainpatent rights for the mRNA-based shot.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":148,"commentSize":24,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}